Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
12/2014
12/04/2014US20140357622 Crystalline forms of sodium 4--2-methoxybenzoate
12/04/2014US20140357621 Organic Compounds
12/04/2014US20140357614 Diamino-Pyridine, Pyrimidine, and Pyrazine Modulators of the Histamine H4 Receptor
12/04/2014US20140357612 Compounds for kinase modulation, and indications therefor
12/04/2014US20140357606 Organic compounds
12/04/2014US20140356430 Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, a solid form thereof and methods of their use
12/04/2014US20140356360 Piperazinyl derivatives for the treatment of cancer
12/02/2014US8901313 6,5-heterocyclic propargylic alcohol compounds and uses therefor
12/02/2014US8901312 Cyclic compound, method for producing cyclic compound, and method for modifying biological molecule
12/02/2014US8901300 Tetraazapyrene compounds and their use as N-type semiconductors
12/02/2014US8901293 Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
12/02/2014US8901292 Method of mass production of tetrakis(p-nitrophenyl)porphyrins
12/02/2014US8901142 Fused tricyclic compounds as mTOR inhibitors
12/02/2014US8901141 Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them
12/02/2014US8901136 Heteroaryl compounds useful as inhibitors of E1 activating enzymes
12/02/2014US8901135 Heterocyclic compounds and their uses
12/02/2014US8901134 Pyrazolo [3,4-D] pyrimidine derivatives useful to treat respiratory disorders
12/02/2014US8901133 Heterocyclic compounds and uses thereof
12/02/2014US8901126 Substituted imidazo[1,5-A]quinoxalin-4-ones are useful for preventing or treating storage dysfunction, voiding dysfunction and bladder/urethral diseases
12/02/2014US8901123 Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-B][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
12/02/2014US8901118 Compounds and methods for kinase modulation, and indications therefor
12/02/2014US8901117 Small molecule inhibitors of MDM2 and the uses thereof
12/02/2014US8901115 Cyclic P1 linkers as factor XIa inhibitors
12/02/2014US8901111 Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase
12/02/2014US8901087 Selective glycosidase inhibitors and uses thereof
12/02/2014US8900830 Process for producing optically active succinimide derivatives
11/2014
11/27/2014US20140350253 Asymmetric electrophilic fluorination using an anionic chiral phase-transfer catalyst
11/27/2014US20140350250 Therapeutic agent for cerebral infarction
11/27/2014US20140350249 Therapeutic agent for cerebral infarction
11/27/2014US20140350244 Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors
11/27/2014US20140350040 2 - (pyridin- 2yl) - 1, 7 -diaza-spiro [4.4] nonane- 6 -one compound as voltage-gated sodium channels modulator
11/27/2014US20140350036 Agents that prevent or repair skin damage
11/27/2014US20140350034 Aminopyridine derivatives as plasma kallikrein inhibitors
11/27/2014US20140350025 Compounds for the treatment of cns disorders
11/27/2014US20140350023 Amorphous form of sitagliptin salts
11/27/2014US20140350012 Piperidine/piperazine derivatives
11/27/2014US20140350010 Pyrazolopyrrolidine Compounds
11/27/2014US20140349998 Pyrrolopyrimidines as janus kinase inhiitors
11/27/2014US20140349993 Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
11/27/2014US20140349992 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
11/27/2014US20140349990 Pyrazolopyrrolidine Derivatives and their Use in the Treatment of Disease
11/27/2014US20140349986 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
11/27/2014US20140349970 Novel tricyclic compounds
11/25/2014US8895750 Heteroaromatic compounds as BTK inhibitors
11/25/2014US8895745 Bicyclic heterocyclic compounds as FGFR inhibitors
11/25/2014US8895741 Process for the synthesis of biaryl oxazolidinones
11/25/2014US8895740 Pyrazolopyrazine kinase inhibitors
11/25/2014US8895739 Acylation of hindered amines and functionalized bis-peptides obtained thereby
11/25/2014US8895736 Synthesis of substituted 2-nitromalonaldehyde intermediates toward the preparation of polyaza-adamantanes
11/25/2014US8895735 Preparation process of (6R)-tetrahydrobiopterin hydrochloride
11/25/2014US8895733 Triazine-oxadiazoles
11/25/2014US8895727 Method for preparation of fluorine-18-labeled flumazenil using diaryliodonium salt precursor
11/25/2014US8895603 Crystalline forms of a dipeptidyl peptidase-IV inhibitor
11/25/2014US8895601 Pyrazolyl quinoxaline kinase inhibitors
11/25/2014US8895599 Lipoprotein lipase-activating compositions comprising benzene derivates
11/25/2014US8895582 Certain chemical entities, compositions, and methods
11/25/2014US8895580 Quinolinone-pyrazolone M1 receptor positive allosteric modulators
11/25/2014US8895572 Fused heterocyclic indane carboxamide CGRP receptor antagonists
11/25/2014US8895571 Isoindolinone and pyrrolopyridinone derivatives as Akt inhibitors
11/25/2014US8895566 5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors
11/25/2014US8895554 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease
11/25/2014US8895549 Aminoalcohol substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
11/25/2014US8895544 Indazoles
11/25/2014US8895543 Vinca derivatives
11/25/2014US8895313 Ligands for aggregated tau molecules
11/25/2014US8895207 Materials and their use for the electrocatalytic evolution or uptake of H2
11/20/2014US20140343282 Processes for making ponatinib and intermediates thereof
11/20/2014US20140343276 Macrocycles as factor xia inhibitors
11/20/2014US20140343084 Imidazopyrrolidinone compounds
11/20/2014US20140343066 5-substituted indazoles as kinase inhibitors
11/20/2014US20140343065 New Somatostatin receptor subtype 4 (SSTR4) agonists
11/20/2014US20140343057 Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using pi3 kinase inhibitors
11/20/2014US20140343046 Use of selective gaba a alpha 5 negative allosteric modulators for the treatment of central nervous system conditions
11/20/2014US20140343045 Modulators of Aldehyde Dehydrogenase and Methods of Use Thereof
11/20/2014US20140343040 Pentylenetetrazole derivatives
11/20/2014US20140343035 3,5-disubstituted alkynylbenzene compound and salt thereof
11/20/2014US20140343032 Novel 6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
11/20/2014US20140343018 Anti-depression Compounds
11/20/2014US20140343015 Morphinan derivative
11/20/2014US20140341851 Novel benzimidazole derivatives
11/18/2014US8889885 Method for producing nanoparticles
11/18/2014US8889870 Kinase inhibitors
11/18/2014US8889862 2-amino-4-arylthiazole compounds as TRPA1 antagonists
11/18/2014US8889860 3′-OH unblocked, fast photocleavable terminating nucleotides and methods for nucleic acid sequencing
11/18/2014US8889854 C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity
11/18/2014US8889708 Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C
11/18/2014US8889704 Triazolopyridine compounds as PIM kinase inhibitors
11/18/2014US8889703 Inhibitors of beta-secretase
11/18/2014US8889700 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
11/18/2014US8889697 Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
11/18/2014US8889696 Substituted pyrido[2,3-d]pyrimidin-7(8H)-ones and therapeutic uses thereof
11/18/2014US8889691 Indole compounds as an inhibitor of cellular necrosis
11/18/2014US8889686 Method of decreasing the bitterness of a pharmaceutical dosage form containing zopiclone
11/18/2014US8889685 Method for treating a sleep disorder with eszopiclone maleate
11/18/2014US8889684 Azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors
11/18/2014US8889681 Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm-related clinical pathologies
11/18/2014US8889669 Cytotoxic benzodiazepine derivatives
11/18/2014US8889667 Therapeutic compounds and compositions
11/18/2014US8889666 Quinolyl pyrrolo pyrimidyl condensed-ring compound and salt thereof
11/18/2014US8889665 Chemical compounds
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 573